These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4380496)

  • 1. The effect of bamethan on cardiovascular response.
    Parker CE; Edwards AE; Cohen S
    J New Drugs; 1966; 6(1):55-61. PubMed ID: 4380496
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double blind trial of hexoprenaline as a bronchodilator].
    Ulmer WT
    Arzneimittelforschung; 1974 May; 24(5):840-1. PubMed ID: 4603484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. I. Subcutaneous comparison with epinephrine.
    Glass P; Dulfano MJ
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):141-9. PubMed ID: 4144566
    [No Abstract]   [Full Text] [Related]  

  • 5. Bamethan A competitive betamimetic drug.
    Marmo E; Saini RK; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):247-72. PubMed ID: 4152789
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a new B 2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. II. Oral comparison with ephedrine.
    Dulfano MJ; Glass P
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):150-7. PubMed ID: 4144567
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients.
    Eckert M; Cocco G; Strozzi C; Heizmann P; Sfrisi C
    Eur J Clin Pharmacol; 1983; 24(4):479-84. PubMed ID: 6134625
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.
    Guhan AR; Cooper S; Oborne J; Lewis S; Bennett J; Tattersfield AE
    Thorax; 2000 Aug; 55(8):650-6. PubMed ID: 10899240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The electrophysiological effects of intravenous labetalol in man.
    Harley A; Coverdale HA
    Eur J Clin Pharmacol; 1981; 20(4):241-4. PubMed ID: 7308279
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hexoprenaline on blood pressure].
    Lageder H; Hitzenberger G; Thoma F; Irsigler K
    Int J Clin Pharmacol; 1974 Sep; 10(2):90-4. PubMed ID: 4448556
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pharmacological properties of Midodrin and its clinical application in patients with hypotensive circulatory disturbance (author's transl)].
    Lachner O; Lillie C; Rot A
    Wien Klin Wochenschr; 1974 Jun; 86(12):344-8. PubMed ID: 4600383
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of oral terbutaline in asthma.
    Kanarek DJ; Goldman HI; Zwi S
    Acta Allergol; 1972 Sep; 27(4):302-6. PubMed ID: 4678790
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind trial with increasing doses of salbutamol and terbutaline aerosols in patients with reversible airways obstruction.
    Simonsson BG; Stiksa J; Ström B
    Acta Med Scand; 1972 Nov; 192(5):371-6. PubMed ID: 4563324
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of labetalol on continuous ambulatory blood pressure.
    Balasubramanian V; Mann S; Raftery EB; Millar-Craig MW; Altman D
    Br J Clin Pharmacol; 1979; 8(Suppl 2):119S-123S. PubMed ID: 526391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of beta-adrenergic receptor blockade on the blood pressure and heart rate changes induced by noradrenaline infusion and postinfusional hypotension.
    Mazurkiewicz IM
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):136-58. PubMed ID: 4384633
    [No Abstract]   [Full Text] [Related]  

  • 17. Nebivolol lowers blood pressure and increases weight loss in patients with hypertension and diabetes in regard to age.
    Ladage D; Reidenbach C; Rieckeheer E; Graf C; Schwinger RH; Brixius K
    J Cardiovasc Pharmacol; 2010 Sep; 56(3):275-81. PubMed ID: 20571428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI; Silke B; Barker MC; Saxton CA; Taylor SH
    Eur Heart J; 1982 Jun; 3(3):238-45. PubMed ID: 6125392
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchodilator effect of hexoprenalin administered in a dosed aerosol form (spirographic evaluation)].
    Cornudella R; Castellano A; Santafé G
    Rev Clin Esp; 1973 Jun; 129(5):469-76. PubMed ID: 4732991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.